Zota Health Care Limited has voluntarily fixed an upper cap limit for the cumulative remuneration payable to its Promoter Directors. The company has established that the total remuneration, including all perquisites and allowances, shall not exceed ₹12.00 crores in aggregate for a single financial year. This decision is part of an initiative to adopt better corporate governance practices and to moderate managerial remuneration while ensuring better allocation of capital for the company's growth.

The resolution follows representations received from key members of the promoter and promoter group. The directors who proposed this measure include Mr. Ketankumar Chandulal Zota, Non-executive Chairman; Mr. Moxesh Ketanbhai Zota, Managing Director; and Whole-time Directors Mr. Himanshu Muktilal Zota, Mr. Kamlesh Rajanikant Zota, and Mr. Viren Manukant Zota.

Validity and Approvals

The fixed upper cap limit of ₹12.00 crores is valid until the end of the financial year 2030. The implementation of this remuneration structure is subject to necessary approvals whenever applicable. The company communicated this decision to the stock exchanges to ensure compliance with regulatory disclosure requirements.

Key Details of Remuneration Cap

zota healthcare has appointed Mr. Akshay Kumar as the brand ambassador for the company and its UGO Generic brand. The legendary actor and fitness icon will represent the company and the brand operated by M/s KMHP Ventures Limited, a Wholly Owned Subsidiary of Zota Health Care Limited. This strategic move is aimed at catalyzing brand expansion and strengthening the company's national presence.

UGO Generic is designed as a B2B and B2C brand that will offer high-quality generic medicines on a PAN India basis. The distribution strategy includes selling through owned stores as well as approximately 12.5 lakh retail pharmacies that are planned to be onboarded under the UGO Generic network. The company believes that Mr. Kumar's association will add significant strength and mass connect as it advances its vision of making affordable, high-quality generic medicines accessible across the country.

Strategic Alignment and Vision

The collaboration is viewed as a defining milestone for Zota Health Care Limited as it seeks to deepen consumer trust. The company highlighted that Mr. Kumar's reputation for discipline, resilience, and enduring excellence aligns with the core values of Zota and UGO Generic—trust, reach, and a mission to make quality healthcare available to every home in India.

Mr. Ketankumar Zota, Chairman of Zota Health Care Limited, commented on the development, stating that the company is delighted to welcome Mr. Akshay Kumar to the Zota family. He noted that Mr. Kumar's influence extends beyond cinema and that his qualities of discipline, reliability, and integrity align closely with the company's mission of making healthcare affordable and accessible.

Company Overview

Zota Health Care Ltd., listed on the NSE, has been operating in the Indian healthcare industry since 2000. Headquartered in Surat, the company employs over 520 professionals and specializes in the development, manufacturing, and marketing of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. The company operates through three main divisions: marketing, export, and the retail pharmacy chain.

In 2017, the company launched Davaindia, a generic pharmacy chain offering over 2,000 SKUs of quality medicines. This strategic business model utilizes backward and forward integration to manage the entire product life cycle efficiently. The company continues to invest in its Research and Development team to pioneer healthcare solutions.